IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC Wakelee, H., Altorki, N., Felip, E., Vallieres, E., Vynnychenko, I. O., Akopov, A., Martinez-Marti, A., Chella, A., Bondarenko, I., Sugawara, S., Fan, Y., Kenmotsu, H., Chen, Y., Deng, Y., Wu, F., McNally, V., Bennett, E., Gitlitz, B. J., Zhou, C. ELSEVIER SCIENCE INC. 2022: S2

View details for Web of Science ID 000858678100004